(A) & (B) - In the PK model, Group I showed significantly less total neovascularization compared to Groups II and III (p=0.043, p=0.020, respectively) and less total lymphangiogenesis (p=0.005) and less graft lymphangiogenesis (p=0.020) compared to Group III.
(C) Representative pictures of Group I, II, and III. Upper row: CD31staining, Lower row: LYVE-1 staining